Literature DB >> 21964574

Mutations in TRPV4 cause an inherited arthropathy of hands and feet.

Shireen R Lamandé1, Yuan Yuan, Irma L Gresshoff, Lynn Rowley, Daniele Belluoccio, Kumara Kaluarachchi, Christopher B Little, Elke Botzenhart, Klaus Zerres, David J Amor, William G Cole, Ravi Savarirayan, Peter McIntyre, John F Bateman.   

Abstract

Familial digital arthropathy-brachydactyly (FDAB) is a dominantly inherited condition that is characterized by aggressive osteoarthropathy of the fingers and toes and consequent shortening of the middle and distal phalanges. Here we show in three unrelated families that FDAB is caused by mutations encoding p.Gly270Val, p.Arg271Pro and p.Phe273Leu substitutions in the intracellular ankyrin-repeat domain of the cation channel TRPV4. Functional testing of mutant TRPV4 in HEK-293 cells showed that the mutant proteins have poor cell-surface localization. Calcium influx in response to the synthetic TRPV4 agonists GSK1016790A and 4αPDD was significantly reduced, and mutant channels did not respond to hypotonic stress. Others have shown that gain-of-function TRPV4 mutations cause skeletal dysplasias and peripheral neuropathies. Our data indicate that TRPV4 mutations that reduce channel activity cause a third phenotype, inherited osteoarthropathy, and show the importance of TRPV4 activity in articular cartilage homeostasis. Our data raise the possibility that TRPV4 may also have a role in age- or injury-related osteoarthritis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21964574     DOI: 10.1038/ng.945

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  33 in total

1.  OTRPC4, a nonselective cation channel that confers sensitivity to extracellular osmolarity.

Authors:  R Strotmann; C Harteneck; K Nunnenmacher; G Schultz; T D Plant
Journal:  Nat Cell Biol       Date:  2000-10       Impact factor: 28.824

2.  Temperature-modulated diversity of TRPV4 channel gating: activation by physical stresses and phorbol ester derivatives through protein kinase C-dependent and -independent pathways.

Authors:  Xiaochong Gao; Ling Wu; Roger G O'Neil
Journal:  J Biol Chem       Date:  2003-05-08       Impact factor: 5.157

3.  Human TRPV4 channel splice variants revealed a key role of ankyrin domains in multimerization and trafficking.

Authors:  Maite Arniges; José M Fernández-Fernández; Nadine Albrecht; Michael Schaefer; Miguel A Valverde
Journal:  J Biol Chem       Date:  2005-11-16       Impact factor: 5.157

4.  ADAMTS-1-knockout mice do not exhibit abnormalities in aggrecan turnover in vitro or in vivo.

Authors:  Chris B Little; Laureane Mittaz; Daniele Belluoccio; Fraser M Rogerson; Ian K Campbell; Clare T Meeker; John F Bateman; Melanie A Pritchard; Amanda J Fosang
Journal:  Arthritis Rheum       Date:  2005-05

5.  CMT2C with vocal cord paresis associated with short stature and mutations in the TRPV4 gene.

Authors:  D-H Chen; Y Sul; M Weiss; A Hillel; H Lipe; J Wolff; M Matsushita; W Raskind; T Bird
Journal:  Neurology       Date:  2010-11-30       Impact factor: 9.910

6.  Mutant TRPV4-mediated toxicity is linked to increased constitutive function in axonal neuropathies.

Authors:  Faisal Fecto; Yong Shi; Rafiq Huda; Marco Martina; Teepu Siddique; Han-Xiang Deng
Journal:  J Biol Chem       Date:  2011-03-21       Impact factor: 5.157

7.  Mutations in the heparan-sulfate proteoglycan glypican 6 (GPC6) impair endochondral ossification and cause recessive omodysplasia.

Authors:  Ana Belinda Campos-Xavier; Danielle Martinet; John Bateman; Dan Belluoccio; Lynn Rowley; Tiong Yang Tan; Alica Baxová; Karl-Henrik Gustavson; Zvi U Borochowitz; A Micheil Innes; Sheila Unger; Jacques S Beckmann; Lauréane Mittaz; Diana Ballhausen; Andrea Superti-Furga; Ravi Savarirayan; Luisa Bonafé
Journal:  Am J Hum Genet       Date:  2009-05-28       Impact factor: 11.025

8.  Functional characterization of TRPV4 as an osmotically sensitive ion channel in porcine articular chondrocytes.

Authors:  Mimi N Phan; Holly A Leddy; Bartholomew J Votta; Sanjay Kumar; Dana S Levy; David B Lipshutz; Suk Hee Lee; Wolfgang Liedtke; Farshid Guilak
Journal:  Arthritis Rheum       Date:  2009-10

9.  S100A8 and S100A9 in experimental osteoarthritis.

Authors:  Hala Zreiqat; Daniele Belluoccio; Margaret M Smith; Richard Wilson; Lynn A Rowley; Katie Jones; Yogambha Ramaswamy; Thomas Vogl; Johannes Roth; John F Bateman; Christopher B Little
Journal:  Arthritis Res Ther       Date:  2010-01-27       Impact factor: 5.156

10.  Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes.

Authors:  Jo Vandesompele; Katleen De Preter; Filip Pattyn; Bruce Poppe; Nadine Van Roy; Anne De Paepe; Frank Speleman
Journal:  Genome Biol       Date:  2002-06-18       Impact factor: 13.583

View more
  58 in total

1.  TRPV4 mediates myofibroblast differentiation and pulmonary fibrosis in mice.

Authors:  Shaik O Rahaman; Lisa M Grove; Sailaja Paruchuri; Brian D Southern; Susamma Abraham; Kathryn A Niese; Rachel G Scheraga; Sudakshina Ghosh; Charles K Thodeti; David X Zhang; Magdalene M Moran; William P Schilling; Daniel J Tschumperlin; Mitchell A Olman
Journal:  J Clin Invest       Date:  2014-11-03       Impact factor: 14.808

2.  The postnatal role of Sox9 in cartilage.

Authors:  Stephen P Henry; Shoudan Liang; Kadir C Akdemir; Benoit de Crombrugghe
Journal:  J Bone Miner Res       Date:  2012-12       Impact factor: 6.741

3.  Tripping out on TRPV4.

Authors:  Friedrich C Luft
Journal:  J Mol Med (Berl)       Date:  2015-12       Impact factor: 4.599

4.  Yeast luminometric and Xenopus oocyte electrophysiological examinations of the molecular mechanosensitivity of TRPV4.

Authors:  Jinfeng Teng; Stephen Loukin; Xinliang Zhou; Ching Kung
Journal:  J Vis Exp       Date:  2013-12-31       Impact factor: 1.355

5.  TRPV4-mediated calcium signaling in mesenchymal stem cells regulates aligned collagen matrix formation and vinculin tension.

Authors:  Christopher L Gilchrist; Holly A Leddy; Laurel Kaye; Natasha D Case; Katheryn E Rothenberg; Dianne Little; Wolfgang Liedtke; Brenton D Hoffman; Farshid Guilak
Journal:  Proc Natl Acad Sci U S A       Date:  2019-01-23       Impact factor: 11.205

6.  The tyrosine kinase inhibitor bafetinib inhibits PAR2-induced activation of TRPV4 channels in vitro and pain in vivo.

Authors:  M S Grace; T Lieu; B Darby; F C Abogadie; N Veldhuis; N W Bunnett; P McIntyre
Journal:  Br J Pharmacol       Date:  2014-08       Impact factor: 8.739

7.  Deficient transient receptor potential vanilloid type 4 function contributes to compromised [Ca2+]i homeostasis in human autosomal-dominant polycystic kidney disease cells.

Authors:  Viktor Tomilin; Gail A Reif; Oleg Zaika; Darren P Wallace; Oleh Pochynyuk
Journal:  FASEB J       Date:  2018-03-19       Impact factor: 5.191

8.  Patient-derived skeletal dysplasia induced pluripotent stem cells display abnormal chondrogenic marker expression and regulation by BMP2 and TGFβ1.

Authors:  Biagio Saitta; Jenna Passarini; Dhruv Sareen; Loren Ornelas; Anais Sahabian; Shilpa Argade; Deborah Krakow; Daniel H Cohn; Clive N Svendsen; David L Rimoin
Journal:  Stem Cells Dev       Date:  2014-04-01       Impact factor: 3.272

9.  Follistatin in chondrocytes: the link between TRPV4 channelopathies and skeletal malformations.

Authors:  Holly A Leddy; Amy L McNulty; Suk Hee Lee; Nicole E Rothfusz; Bernd Gloss; Margaret L Kirby; Mary R Hutson; Daniel H Cohn; Farshid Guilak; Wolfgang Liedtke
Journal:  FASEB J       Date:  2014-02-27       Impact factor: 5.191

10.  Transcriptomic analyses of genes and tissues in inherited sensory neuropathies.

Authors:  Matthew R Sapio; Samridhi C Goswami; Jacklyn R Gross; Andrew J Mannes; Michael J Iadarola
Journal:  Exp Neurol       Date:  2016-06-23       Impact factor: 5.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.